Aims There is considerable variability in the effect of intravenous iron on hard cardiovascular
(CV)‐related outcomes in patients with heart failure (HF) in randomized controlled trials …

Abstract Background The recent AFFIRM-AHF trial assessing the effect of intravenous (IV)
iron on outcomes in patients hospitalised with worsening heart failure who had iron …

Aims For patients with heart failure (HF) and iron deficiency (ID), randomized trials suggest
that intravenous (IV) iron reduces hospitalizations for heart failure (HHF), but uncertainty …

Background Guidelines recommend that intravenous iron should be considered to improve
symptoms of heart failure (HF) and reduce the risk for HF admissions in patients after acute …

Aims The aim of this study was to assess the net clinical and prognostic effects of
intravenous (iv) iron therapy in patients with systolic heart failure (HF) and iron deficiency …

Background The effectiveness of oral and intravenous iron supplementation in reducing the
risk of mortality and hospitalizations in HF patients with iron deficiency is not well …

(1) Background: Iron deficiency (ID) is an important adverse prognostic marker in patients
with heart failure (HF); however, it is unclear whether intravenous iron replacement reduces …

Background Iron deficiency (ID) is a common comorbidity in patients with heart failure (HF)
and has been associated with increased mortality and hospitalizations. However, the benefit …

Aims Iron deficiency is common in patients with heart failure (HF) and reduced ejection
fraction (HFrEF) and is associated with a poor prognosis. Whether intravenous iron …

Trials studying iron administration in patients with chronic heart failure (CHF) and iron
deficiency (ID) have sprung up these years but the results remain inconsistent. The aim of …